| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adenopathy and extensive skin patch overlying a plasmacytoma (AESOP) syndrome: a case report and literature review
|
Yan, Wenqiang
|
|
|
103 |
1 |
p. 339-341
|
article
|
| 2 |
Allogeneic hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia
|
Tian, Jieyu
|
|
|
103 |
1 |
p. 297-305
|
article
|
| 3 |
A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents
|
Bewersdorf, Jan Philipp
|
|
|
103 |
1 |
p. 105-116
|
article
|
| 4 |
A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma
|
Merryman, Reid W.
|
|
|
103 |
1 |
p. 185-198
|
article
|
| 5 |
A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group
|
Barilà, Gregorio
|
|
|
103 |
1 |
p. 125-132
|
article
|
| 6 |
CD45 inhibition in myeloid leukaemia cells sensitizes cellular responsiveness to chemotherapy
|
Al Barashdi, Maryam Ahmed S.
|
|
|
103 |
1 |
p. 73-88
|
article
|
| 7 |
CLAG combined with total body irradiation as intensive conditioning chemotherapy prior to allogeneic hematopoietic stem cell transplantation in patients with refractory or relapsed acute myeloid leukemia
|
Fei, Xinhong
|
|
|
103 |
1 |
p. 241-249
|
article
|
| 8 |
Clinical factors associated with autologous stem cell transplantation outcomes in multiple myeloma: upfront transplant with MEL200 remains the standard of care
|
Bostankolu Değirmenci, Başak
|
|
|
103 |
1 |
p. 269-283
|
article
|
| 9 |
Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study
|
Wei, Yu-Ce
|
|
|
103 |
1 |
p. 163-174
|
article
|
| 10 |
Clinical outcome of breakthrough COVID-19 in multiple myeloma patients after three or more anti-SARS-CoV-2 vaccine doses: a single center analysis of 64 cases
|
Sgherza, Nicola
|
|
|
103 |
1 |
p. 351-355
|
article
|
| 11 |
Correction to: A case of sudden hearing loss in a patient with chronic myelomonocytic leukemia
|
Babakhanlou, Rodrick
|
|
|
103 |
1 |
p. 371
|
article
|
| 12 |
Correction to: Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B‑cell lymphoma: results of a multicentric prospective cohort study
|
Pénichoux, Juliette
|
|
|
103 |
1 |
p. 369
|
article
|
| 13 |
Detection of a rare JAK2exon13InDel-mutation in chronic eosinophilic leukemia with bilateral cerebral infarctions and Löffler endocarditis
|
Eisenach, Sven
|
|
|
103 |
1 |
p. 363-365
|
article
|
| 14 |
Development and validation of a novel risk stratification model and a survival rate calculator for diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study
|
Zhong, Qiaofeng
|
|
|
103 |
1 |
p. 211-226
|
article
|
| 15 |
Down-regulation of Musashi-2 exerts antileukemic effects on acute lymphoblastic leukemia cells and increases sensitivity to dexamethasone
|
Zou, Duobing
|
|
|
103 |
1 |
p. 141-151
|
article
|
| 16 |
Genetic and clinical characteristics of primary hemophagocytic lymphohistiocytosis in children
|
Zhao, Chenzi
|
|
|
103 |
1 |
p. 17-28
|
article
|
| 17 |
Hereditary thrombocythemia due to splicing donor site mutation of THPO in a Japanese family
|
Kimura, Hiroyuki
|
|
|
103 |
1 |
p. 89-96
|
article
|
| 18 |
Hypomethylating agents (HMAs) show benefit in AML rather than in intermediate/high-risk MDS based on genetic mutations in epigenetic modification (EMMs): from a retrospective study
|
Wang, Ruiqi
|
|
|
103 |
1 |
p. 61-71
|
article
|
| 19 |
Imatinib and CAR T cell therapy enable sustained response in a young patient with refractory RCSD1-ABL1-positive acute lymphoblastic leukemia
|
Cui, Yajuan
|
|
|
103 |
1 |
p. 361-362
|
article
|
| 20 |
Impact of baseline and interim quantitative PET parameters on outcomes of classical Hodgkin Lymphoma
|
Santos, Fernanda Maria
|
|
|
103 |
1 |
p. 175-183
|
article
|
| 21 |
Impact of race and ethnicity on outcomes after autologous stem cell transplantation for patients with newly diagnosed multiple myeloma
|
Davis, James A.
|
|
|
103 |
1 |
p. 251-258
|
article
|
| 22 |
Integrative analyses reveal outcome-associated and targetable molecular partnerships between TP53, BRD4, TNFRSF10B, and CDKN1A in diffuse large B-cell lymphoma
|
Forberg, Aidan L.
|
|
|
103 |
1 |
p. 199-209
|
article
|
| 23 |
Investigating the correlation between small molecular inhibitor utilization, peripheral blood monocytes, and treatment outcomes in Rosai Dorfman disease
|
Reynolds, Samuel B.
|
|
|
103 |
1 |
p. 37-59
|
article
|
| 24 |
Low fixed dose pembrolizumab with gemcitabine, vinorelbine, liposomal doxorubicin (Pembro100 -GVD) as an effective salvage regimen in relapsed refractory classical hodgkin’s lymphoma and primary mediastinal B cell lymphoma
|
Panda, Tribikram
|
|
|
103 |
1 |
p. 347-349
|
article
|
| 25 |
Men treated with BEACOPP for Hodgkin lymphoma may be at increased risk of testosterone deficiency
|
Micas Pedersen, Signe
|
|
|
103 |
1 |
p. 227-239
|
article
|
| 26 |
Osteolytic lesion as initial presentation in FIP1L1-PDGFRA-rearranged myeloid/lymphoid neoplasm with eosinophilia: a case report
|
Lv, Yunfei
|
|
|
103 |
1 |
p. 357-360
|
article
|
| 27 |
Outcome improvement over time in reduced intensity conditioning hematopoietic transplantation: a 20-year experience
|
Esquirol, Albert
|
|
|
103 |
1 |
p. 321-334
|
article
|
| 28 |
Outcomes of allogeneic hematopoietic cell transplantation under letermovir prophylaxis for cytomegalovirus infection
|
Takenaka, Katsuto
|
|
|
103 |
1 |
p. 285-296
|
article
|
| 29 |
Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study: The JALSG-CS11-MDS-SCT
|
Nakagawa, Noriharu
|
|
|
103 |
1 |
p. 307-320
|
article
|
| 30 |
Overcoming right heart failure through successful treatment of cardiac dominant diffuse large B-cell lymphoma: a case report
|
Huang, Xianbo
|
|
|
103 |
1 |
p. 343-345
|
article
|
| 31 |
Predictive value of pre-infusion tumor growth rate for the occurrence and severity of CRS and ICANS in lymphoma under CAR T-cell therapy
|
Winkelmann, Michael
|
|
|
103 |
1 |
p. 259-268
|
article
|
| 32 |
Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria
|
Schrezenmeier, Hubert
|
|
|
103 |
1 |
p. 5-15
|
article
|
| 33 |
Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis
|
Shide, Kotaro
|
|
|
103 |
1 |
p. 97-103
|
article
|
| 34 |
Retrospective cohort evaluation of non-HIV Castleman disease from a single academic center in Beijing, China
|
Guo, Meiyu
|
|
|
103 |
1 |
p. 153-162
|
article
|
| 35 |
Screening results and mutation frequency analysis of G6PD deficiency in 1,291,274 newborns in Huizhou, China: a twenty-year experience
|
Zhang, Zhiqiang
|
|
|
103 |
1 |
p. 29-36
|
article
|
| 36 |
Small bowel lesions in patients with iron deficiency anaemia without overt bleeding: a multicentre study
|
Zullo, Angelo
|
|
|
103 |
1 |
p. 1-4
|
article
|
| 37 |
Successful use of venetoclax combined with azacitidine in isolated extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a case report
|
Lin, Qingqing
|
|
|
103 |
1 |
p. 335-337
|
article
|
| 38 |
T-large granular lymphocyte frequencies and correlates in disease states detected by multiparameter flow cytometry in pediatric and young adult population
|
Gadgeel, Manisha
|
|
|
103 |
1 |
p. 133-140
|
article
|
| 39 |
Unicentric Castleman’s disease presenting as amyloid A cardiac amyloidosis: a case report
|
Zhang, Miao-yan
|
|
|
103 |
1 |
p. 367-368
|
article
|
| 40 |
Young patients with myelofibrosis have distinct clinicomolecular features, favorable prognosis, and commonly exhibit inflammatory comorbidities
|
Horvat, Nathan P.
|
|
|
103 |
1 |
p. 117-123
|
article
|
Journal description